WO2010019016A3 - 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물 - Google Patents

산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2010019016A3
WO2010019016A3 PCT/KR2009/004563 KR2009004563W WO2010019016A3 WO 2010019016 A3 WO2010019016 A3 WO 2010019016A3 KR 2009004563 W KR2009004563 W KR 2009004563W WO 2010019016 A3 WO2010019016 A3 WO 2010019016A3
Authority
WO
WIPO (PCT)
Prior art keywords
ginseng
liver diseases
cambium
cell lines
lines derived
Prior art date
Application number
PCT/KR2009/004563
Other languages
English (en)
French (fr)
Other versions
WO2010019016A2 (ko
Inventor
진영우
이은경
임민정
김영미
홍선미
장미옥
구인숙
최금이
Original Assignee
주식회사 운화바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 운화바이오텍 filed Critical 주식회사 운화바이오텍
Priority to US13/058,949 priority Critical patent/US20120189660A1/en
Priority to CA2734101A priority patent/CA2734101A1/en
Priority to CN200980135446.2A priority patent/CN102316883B/zh
Priority to EP09806878A priority patent/EP2335712A4/en
Priority to AU2009280402A priority patent/AU2009280402A1/en
Priority to JP2011522914A priority patent/JP2011530583A/ja
Publication of WO2010019016A2 publication Critical patent/WO2010019016A2/ko
Publication of WO2010019016A3 publication Critical patent/WO2010019016A3/ko
Priority to US13/863,829 priority patent/US9289457B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/005—Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04—Plant cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)

Abstract

본 발명은 산삼 또는 인삼을 포함하는 인삼류(Panax ginseng)의 형성층 유래 동질적인 세포주, 그 파쇄물, 그 추출물 및 그 배양물 중 어느 하나 이상을 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물에 관한 것이다. 본 발명에 따른 인삼류의 형성층 유래 동질적인 세포주, 그 파쇄물, 그 추출물 및 그 배양물은 기존 간질환 치료제의 부작용을 최소화하여 인체에 안전하면서도, 간염 바이러스에 대한 s 항체 (HBsAb) 및 e 항체(HBeAb)를 증가시키는 효과가 있으며, 간염 바이러스의 증식을 억제할 수 있으므로, 간질환의 예방 및 치료에 유용하다. 아울러, 간손상 수치를 감소시키는 효과가 있는바, 간기능 개선용 기능성 식품으로서 유용하다.
PCT/KR2009/004563 2008-08-14 2009-08-14 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물 WO2010019016A2 (ko)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US13/058,949 US20120189660A1 (en) 2008-08-14 2009-08-14 Composition for Preventing or Treating Liver Diseases, Containing Plant Stem Cell Lines Derived from the Cambium of Panax Ginseng Including Mountain Ginseng or Ginseng as Active Ingredient
CA2734101A CA2734101A1 (en) 2008-08-14 2009-08-14 Composition for preventing or treating liver diseases containing plant stem cell lines derived from cambium of panax ginseng including wild ginseng or ginseng as active components
CN200980135446.2A CN102316883B (zh) 2008-08-14 2009-08-14 含有包括野山参或人参的人参类的形成层来源的植物干细胞系作为有效成分的肝疾病的预防或治疗用组合物
EP09806878A EP2335712A4 (en) 2008-08-14 2009-08-14 COMPOSITION FOR THE PREVENTION OR TREATMENT OF LIVER DISEASES CONTAINING VEGETABLE STEM CELL LINES DERIVED FROM PANAX GINSENG CAMBIUM COMPRISING MOUNTAIN GINSENG OR GINSENG AS ACTIVE INGREDIENT
AU2009280402A AU2009280402A1 (en) 2008-08-14 2009-08-14 Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of Panax ginseng including wild ginseng or ginseng as active components
JP2011522914A JP2011530583A (ja) 2008-08-14 2009-08-14 天然高麗人参または高麗人参を含む高麗人参類の形成層由来植物幹細胞株を有効成分として含有する肝疾患の予防または治療用組成物
US13/863,829 US9289457B2 (en) 2008-08-14 2013-04-16 Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of Panax ginseng including mountain ginseng or ginseng as active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0080124 2008-08-14
KR20080080124 2008-08-14

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/058,949 A-371-Of-International US20120189660A1 (en) 2008-08-14 2009-08-14 Composition for Preventing or Treating Liver Diseases, Containing Plant Stem Cell Lines Derived from the Cambium of Panax Ginseng Including Mountain Ginseng or Ginseng as Active Ingredient
US13/863,829 Continuation US9289457B2 (en) 2008-08-14 2013-04-16 Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of Panax ginseng including mountain ginseng or ginseng as active ingredient

Publications (2)

Publication Number Publication Date
WO2010019016A2 WO2010019016A2 (ko) 2010-02-18
WO2010019016A3 true WO2010019016A3 (ko) 2010-06-17

Family

ID=41669503

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/004563 WO2010019016A2 (ko) 2008-08-14 2009-08-14 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물

Country Status (9)

Country Link
US (2) US20120189660A1 (ko)
EP (1) EP2335712A4 (ko)
JP (1) JP2011530583A (ko)
KR (1) KR101179171B1 (ko)
CN (1) CN102316883B (ko)
AU (1) AU2009280402A1 (ko)
CA (1) CA2734101A1 (ko)
RU (1) RU2011109257A (ko)
WO (1) WO2010019016A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
EP1951863B1 (en) 2005-10-31 2015-07-08 Unhwa Corporation Stability of secondary metabolite mass production through syncronized plant cell cultures
KR101064518B1 (ko) * 2007-09-21 2011-09-19 주식회사 운화 저장근을 가지는 초본식물의 형성층 유래 식물줄기세포주 및 이의 분리방법
KR101179171B1 (ko) 2008-08-14 2012-09-03 주식회사 운화 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물
EP2363137A4 (en) 2008-09-30 2012-08-01 Unhwa Corp COMPOSITION FOR THE PREVENTION OR TREATMENT OF AIDS WITH PLANT GINSENG VEGETABLE GAMBLING LINE FROM THE BAMBIUM OF PANAX GINSENG OR GINSENG AS AN ACTIVE SUBSTANCE
KR101591429B1 (ko) 2014-04-07 2016-02-04 강릉원주대학교산학협력단 신규 숙취개선 및 간보호용 조성물
JP6483240B2 (ja) * 2014-08-22 2019-03-13 ウェルキー ホールディングス リミテッドＷｅｌｌｋｅｙ Ｈｏｌｄｉｎｇｓ Ｌｉｍｉｔｅｄ 希少ジンセノサイドを高含量で含有する、山参もしくは高麗人参を含む高麗人参類の抽出物または高麗人参類の形成層由来植物幹細胞もしくはその抽出物の製造方法
CN112852707A (zh) * 2019-11-27 2021-05-28 深圳欧珈再生医学抗衰生物工程有限公司 一种花蕾干细胞及提取方法、花蕾干细胞精华液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010057525A (ko) * 1999-12-23 2001-07-04 한상욱 액체배양시스템을 이용한 산삼의 조직배양방법
KR100448552B1 (ko) * 2003-10-14 2004-09-16 (주)바이오벨류 산삼 배양근 추출물을 함유하는 간 섬유화 치료용 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393133A (en) 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4795742A (en) * 1985-09-24 1989-01-03 Yaguang Liu Therapeutic composition from plant extracts
US5106833A (en) 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
JP2511073Y2 (ja) 1989-05-15 1996-09-18 株式会社福原精機製作所 丸編機
JPH045235A (ja) * 1990-04-19 1992-01-09 Nitsukan Kourai Ninjin Kk 肝炎の予防・治療剤
JP3228534B2 (ja) * 1991-08-30 2001-11-12 日東電工株式会社 血中アルコール濃度低下用組成物
US5212091A (en) 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor
KR100533120B1 (ko) 2003-06-16 2005-12-14 주식회사 운화 바이오텍 형성층을 이용한 식물세포배양 방법
CN1314345C (zh) * 2005-05-19 2007-05-09 重庆元亨药物研究有限公司 一种灵芝茶
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
EP1951863B1 (en) 2005-10-31 2015-07-08 Unhwa Corporation Stability of secondary metabolite mass production through syncronized plant cell cultures
KR101068971B1 (ko) 2007-09-21 2011-09-30 주식회사 운화 분열지연중심부 유래 식물줄기세포주 및 이의 분리방법
KR101064518B1 (ko) 2007-09-21 2011-09-19 주식회사 운화 저장근을 가지는 초본식물의 형성층 유래 식물줄기세포주 및 이의 분리방법
AU2008202078B2 (en) 2007-10-10 2012-05-31 Wellkey Holdings Limited Stability of secondary metabolite mass production through synchronized plant cell cultures
CN101229291B (zh) * 2007-12-26 2011-05-25 陈志强 通过免疫调节治疗病毒性肝炎的中药组合物
KR101100867B1 (ko) 2008-05-14 2012-01-02 주식회사 운화 주목의 형성층 또는 전형성층 유래 식물줄기세포주를 유효성분으로 함유하는 항산화, 항염증 또는 항노화용 조성물
WO2009151302A2 (ko) 2008-06-13 2009-12-17 주식회사 운화바이오텍 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 노화방지 또는 항산화용 조성물
KR101179171B1 (ko) 2008-08-14 2012-09-03 주식회사 운화 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물
CA2742950A1 (en) 2008-11-06 2010-04-14 Unhwa Corporation Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010057525A (ko) * 1999-12-23 2001-07-04 한상욱 액체배양시스템을 이용한 산삼의 조직배양방법
KR100448552B1 (ko) * 2003-10-14 2004-09-16 (주)바이오벨류 산삼 배양근 추출물을 함유하는 간 섬유화 치료용 조성물

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ATTELE A. S. ET AL: "Ginseng Pharmacology, multiple constituents and multiple actions", BIOCHEMICAL PHARMACOLOGY, vol. 58, 1999, pages 1685 - 1693, XP008142868 *
See also references of EP2335712A4 *
YUN T.-K.: "Panax ginseng - a non-organ-specific cancer preventive?", THE LANCET ONCOLOGY, vol. 2, 2001, pages 49 - 55, XP004812138 *

Also Published As

Publication number Publication date
KR101179171B1 (ko) 2012-09-03
CN102316883A (zh) 2012-01-11
RU2011109257A (ru) 2012-09-20
WO2010019016A2 (ko) 2010-02-18
US9289457B2 (en) 2016-03-22
CN102316883B (zh) 2014-10-29
US20130202631A1 (en) 2013-08-08
EP2335712A4 (en) 2012-08-01
CA2734101A1 (en) 2010-02-18
KR20100021369A (ko) 2010-02-24
AU2009280402A1 (en) 2010-02-18
EP2335712A2 (en) 2011-06-22
JP2011530583A (ja) 2011-12-22
US20120189660A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
WO2010019016A3 (ko) 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물
Lin et al. A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa
Kim et al. Ferulic acid protects against carbon tetrachloride-induced liver injury in mice
WO2008064357A3 (en) Nanoparticles for protection of cells from oxidative stress
WO2009125964A3 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
TW200637488A (en) Compositions containing botanical extracts rich in phlorizin and methods for using such compositions in blood glucose modification and to affect aging
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
WO2009142842A3 (en) Novel macrocyclic inhibitors of hepatitis c virus replication
TN2012000135A1 (en) Cyclic peptide inhibitors of hepatitis c virus replication
WO2010085091A3 (en) Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
WO2010053314A3 (ko) 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 암의 예방 또는 치료용 조성물
WO2008112565A3 (en) Method and composition for treating cancer
WO2010048087A3 (en) Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
CN104186737B (zh) 富硒白茶的制备方法及该方法制成的富硒白茶
CN102948510A (zh) 一种具有醒酒护肝作用的保健茶及其制备方法
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
WO2009134616A8 (en) Novel inhibitors of hepatitis c virus replication
CN106673839A (zh) 一种适用于金花茶绿枝扦插育苗的生根剂
WO2009075488A3 (en) Anti-influenza viral composition containing bark or stem extract of alnus japonica
WO2010038991A3 (ko) 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 후천성 면역결핍증의 예방 또는 치료용 조성물
WO2012108749A3 (ko) 흑축 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품
CN103385151A (zh) 一种富含超氧化物歧化酶的苹果栽培方法
WO2011028860A3 (en) Compounds and compositions for treating cancer
WO2011052935A3 (ko) 토복령, 여주 및 동충하초 추출물을 유효성분으로 포함하는 혈당 강하용 조성물
NZ598630A (en) Protective compositions for dermal papilla cells

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980135446.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09806878

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2734101

Country of ref document: CA

Ref document number: 2011522914

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2009280402

Country of ref document: AU

Ref document number: 1035/CHENP/2011

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009806878

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2009280402

Country of ref document: AU

Date of ref document: 20090814

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011109257

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 13058949

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: PI0912454

Country of ref document: BR

ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: PI0912454

Country of ref document: BR